Regueiro MD - Search Results

1

ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. Lichtenstein GR, et al. Among authors: regueiro md. Am J Gastroenterol. 2018 Apr;113(4):481-517. doi: 10.1038/ajg.2018.27. Epub 2018 Mar 27. Am J Gastroenterol. 2018. PMID: 29610508

2

Update in medical treatment of Crohn's disease.

Regueiro MD. Regueiro MD. J Clin Gastroenterol. 2000 Dec;31(4):282-91. doi: 10.1097/00004836-200012000-00004. J Clin Gastroenterol. 2000. PMID: 11129268 Review.

3

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.

Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Regueiro M, et al. Am J Gastroenterol. 2003 Aug;98(8):1821-6. doi: 10.1111/j.1572-0241.2003.07581.x. Am J Gastroenterol. 2003. PMID: 12907338

4

Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement.

Regueiro M, Loftus EV Jr, Steinhart AH, Cohen RD; Inflammatory Bowel Disease Center. Regueiro M, et al. Inflamm Bowel Dis. 2006 Oct;12(10):972-8. doi: 10.1097/01.mib.0000231496.92013.85. Inflamm Bowel Dis. 2006. PMID: 17012968

5

Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.

Regueiro M, Loftus EV Jr, Steinhart AH, Cohen RD. Regueiro M, et al. Inflamm Bowel Dis. 2006 Oct;12(10):979-94. doi: 10.1097/01.mib.0000231495.92013.5e. Inflamm Bowel Dis. 2006. PMID: 17012969

6

A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.

Plevy S, Salzberg B, Van Assche G, Regueiro M, Hommes D, Sandborn W, Hanauer S, Targan S, Mayer L, Mahadevan U, Frankel M, Lowder J. Plevy S, et al. Gastroenterology. 2007 Nov;133(5):1414-22. doi: 10.1053/j.gastro.2007.08.035. Epub 2007 Aug 21. Gastroenterology. 2007. PMID: 17920064 Clinical Trial.

7

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, Johanns J, Blank M, Rutgeerts P; Ustekinumab Crohn's Disease Study Group. Sandborn WJ, et al. Gastroenterology. 2008 Oct;135(4):1130-41. doi: 10.1053/j.gastro.2008.07.014. Epub 2008 Jul 17. Gastroenterology. 2008. PMID: 18706417 Clinical Trial.

8

Postoperative Crohn's disease: prevention and treatment.

El-Hachem S, Regueiro M. El-Hachem S, et al. Expert Rev Gastroenterol Hepatol. 2009 Jun;3(3):249-56. doi: 10.1586/egh.09.21. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19485807 Review.

9

Postoperative management of crohn disease.

Cho SM, Cho SW, Regueiro M. Cho SM, et al. Gastroenterol Clin North Am. 2009 Dec;38(4):753-62. doi: 10.1016/j.gtc.2009.07.008. Gastroenterol Clin North Am. 2009. PMID: 19913212 Review.

10

Preventive therapy in postoperative Crohn's disease.

Swoger JM, Regueiro M. Swoger JM, et al. Curr Opin Gastroenterol. 2010 Jul;26(4):337-43. doi: 10.1097/MOG.0b013e328338f724. Curr Opin Gastroenterol. 2010. PMID: 20571386 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page